Home Cart Sign in  
Chemical Structure| 135900-33-3 Chemical Structure| 135900-33-3

Structure of 135900-33-3

Chemical Structure| 135900-33-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 135900-33-3 ]

CAS No. :135900-33-3
Formula : C6H5F3N2O
M.W : 178.11
SMILES Code : NC1=CC=C(OC(F)(F)F)N=C1
MDL No. :MFCD07374879
InChI Key :HYBWXJYCVPLEPI-UHFFFAOYSA-N
Pubchem ID :45790047

Safety of [ 135900-33-3 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H319
Precautionary Statements:P305+P351+P338

Computational Chemistry of [ 135900-33-3 ] Show Less

Physicochemical Properties

Num. heavy atoms 12
Num. arom. heavy atoms 6
Fraction Csp3 0.17
Num. rotatable bonds 2
Num. H-bond acceptors 5.0
Num. H-bond donors 1.0
Molar Refractivity 35.32
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

48.14 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.23
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.69
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.83
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.45
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.22
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

1.48

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.25
Solubility 1.01 mg/ml ; 0.00566 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.32
Solubility 0.861 mg/ml ; 0.00483 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.29
Solubility 0.911 mg/ml ; 0.00512 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.19 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.93

Application In Synthesis of [ 135900-33-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 135900-33-3 ]

[ 135900-33-3 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 1221172-05-9 ]
  • [ 135900-33-3 ]
YieldReaction ConditionsOperation in experiment
89.4% With palladium 10% on activated carbon; ammonium formate In methanol at 55℃; for 16 h; [00537] A mixture of 81(2.00 g, 9.43 mmols, 1.0 eq), Pd/C (10percent, 1.0 g), HCOONH4 (1.2 g, 18.9 mmols, 2.0 eq.) in MeOH (20 mL) was heated to 55 °C for 16 hours. The reaction mixture was cooled to room temperature, filtered through celite, and the filtrate was concentrated. The residue was partitioned between ethyl acetate (100 mL) and NaOH (4percent in water, 30 mL). The organic layer were washed with brine, dried over Na2SO4, filtered, and concentrated to afford the desired product 82 (1.50 g, 8.38 mmols, 89.4percent) as a yellow oil.
85% With ammonium formate In methanol at 55℃; for 16 h; 3-Amino-6-trifluoromethoxypyridine (52); At 25 0C, palladium (10percent on charcoal, 700 mg) was added with stirring to a solution of 3-amino-2-chloro-6-trifluoromethoxypyridine (51, 1.3 g, 6.1 mmol, 1 eq) and ammonium formate (770 mg, 12.1 mmol, 2 eq) in methanol (20 mL). The reaction mixture was stirred for 16 h at 55 0C before being filtrated under suction and the filtrate evaporated. The residue was partitioned between ethyl acetate (2χ 30 mL) and an aqueous solution of sodium hydroxide (4percent, 30 mL). The combined organic layers were dried over sodium sulfate before being evaporated to afford pure 3-amino-6- trifluoromethoxypyridine (52, 920 mg, 5.2 mmol, 85percent) as colorless crystals; m.p. 31-330C.1H NMR (CDCl3, 300 MHz): δ = 7.66 (d, J= 2.9 Hz, 1 H), 6.97 (dd, J= 8.6, 2.9 Hz, 1 H), 6.76 (d, J = 8.6, 1 H), 3.55 (bs, 2 H). - 19F NMR (CDCl3, 282 MHz): δ = -57.7 - 13C NMR (CDCl3, 75 MHz): δ = 148.8, 141.6, 133.9, 125.8, 120.3 (q, J = 257 Hz), 114.3. - C6H5F3N2O (178): calcd. (percent) C 40.46, H 2.83, N 15.73; found C 40.00, H 2.92, N 15.37.
References: [1] Patent: WO2016/144792, 2016, A1, . Location in patent: Paragraph 00537.
[2] Patent: WO2010/40461, 2010, A1, . Location in patent: Page/Page column 49.
[3] European Journal of Organic Chemistry, 2010, # 31, p. 6043 - 6066.
  • 2
  • [ 1221171-70-5 ]
  • [ 135900-33-3 ]
References: [1] Patent: WO2016/144792, 2016, A1, .
  • 3
  • [ 1221172-02-6 ]
  • [ 135900-33-3 ]
References: [1] Patent: WO2016/144792, 2016, A1, .
  • 4
  • [ 1221172-06-0 ]
  • [ 135900-33-3 ]
References: [1] Patent: WO2016/144792, 2016, A1, .
  • 5
  • [ 1221172-07-1 ]
  • [ 135900-33-3 ]
References: [1] Patent: WO2016/144792, 2016, A1, .
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 135900-33-3 ]

Fluorinated Building Blocks

Chemical Structure| 317810-73-4

A328890 [317810-73-4]

6-(Difluoromethoxy)pyridin-3-amine

Similarity: 0.96

Chemical Structure| 1214345-40-0

A140189 [1214345-40-0]

2-Bromo-6-(difluoromethoxy)pyridine

Similarity: 0.78

Chemical Structure| 1131007-43-6

A110334 [1131007-43-6]

6-(Difluoromethoxy)pyridin-2-amine

Similarity: 0.77

Chemical Structure| 72617-82-4

A183208 [72617-82-4]

6-(2,2,2-Trifluoroethoxy)pyridin-3-amine

Similarity: 0.77

Chemical Structure| 1198103-43-3

A124972 [1198103-43-3]

(6-(Difluoromethoxy)pyridin-3-yl)methanamine

Similarity: 0.77

Ethers

Chemical Structure| 317810-73-4

A328890 [317810-73-4]

6-(Difluoromethoxy)pyridin-3-amine

Similarity: 0.96

Chemical Structure| 1214345-40-0

A140189 [1214345-40-0]

2-Bromo-6-(difluoromethoxy)pyridine

Similarity: 0.78

Chemical Structure| 1131007-43-6

A110334 [1131007-43-6]

6-(Difluoromethoxy)pyridin-2-amine

Similarity: 0.77

Chemical Structure| 72617-82-4

A183208 [72617-82-4]

6-(2,2,2-Trifluoroethoxy)pyridin-3-amine

Similarity: 0.77

Chemical Structure| 1198103-43-3

A124972 [1198103-43-3]

(6-(Difluoromethoxy)pyridin-3-yl)methanamine

Similarity: 0.77

Amines

Chemical Structure| 317810-73-4

A328890 [317810-73-4]

6-(Difluoromethoxy)pyridin-3-amine

Similarity: 0.96

Chemical Structure| 1131007-43-6

A110334 [1131007-43-6]

6-(Difluoromethoxy)pyridin-2-amine

Similarity: 0.77

Chemical Structure| 72617-82-4

A183208 [72617-82-4]

6-(2,2,2-Trifluoroethoxy)pyridin-3-amine

Similarity: 0.77

Chemical Structure| 1198103-43-3

A124972 [1198103-43-3]

(6-(Difluoromethoxy)pyridin-3-yl)methanamine

Similarity: 0.77

Chemical Structure| 6635-91-2

A117721 [6635-91-2]

6-Methoxy-4-methylpyridin-3-amine

Similarity: 0.74

Trifluoromethyls

Chemical Structure| 72617-82-4

A183208 [72617-82-4]

6-(2,2,2-Trifluoroethoxy)pyridin-3-amine

Similarity: 0.77

Chemical Structure| 1221171-70-5

A191630 [1221171-70-5]

2-Chloro-6-(trifluoromethoxy)pyridine

Similarity: 0.76

Chemical Structure| 1221171-98-7

A125660 [1221171-98-7]

2-(Trifluoromethoxy)isonicotinic acid

Similarity: 0.72

Chemical Structure| 1211584-76-7

A166590 [1211584-76-7]

6-Methoxy-5-(trifluoromethyl)pyridin-3-amine

Similarity: 0.69

Chemical Structure| 1008140-70-2

A257503 [1008140-70-2]

(6-(Trifluoromethoxy)pyridin-3-yl)boronic acid

Similarity: 0.67

Related Parent Nucleus of
[ 135900-33-3 ]

Pyridines

Chemical Structure| 317810-73-4

A328890 [317810-73-4]

6-(Difluoromethoxy)pyridin-3-amine

Similarity: 0.96

Chemical Structure| 1214345-40-0

A140189 [1214345-40-0]

2-Bromo-6-(difluoromethoxy)pyridine

Similarity: 0.78

Chemical Structure| 1131007-43-6

A110334 [1131007-43-6]

6-(Difluoromethoxy)pyridin-2-amine

Similarity: 0.77

Chemical Structure| 72617-82-4

A183208 [72617-82-4]

6-(2,2,2-Trifluoroethoxy)pyridin-3-amine

Similarity: 0.77

Chemical Structure| 1198103-43-3

A124972 [1198103-43-3]

(6-(Difluoromethoxy)pyridin-3-yl)methanamine

Similarity: 0.77